| Literature DB >> 29354360 |
Ahmed Baligh Laaribi1,2,3, Naila Hannachi2, Hamza Ben Yahia1, Manal Marzouk2, Asma Mehri2,3, Manel Belhadj2, Salwa Yacoub4, Amel Letaief5, Hadda-Imene Ouzari1, Abdellatif Boudabous1, Jalel Boukadida2, Roberta Rizzo6, Inès Zidi1.
Abstract
Human leukocyte antigen (HLA)-F has been involved in immune regulation of infectious diseases. However, the role of HLA-F polymorphisms in hepatitis B infection outcomes remains unclear. Here, we aimed to determine HLA-F polymorphism implication in chronic HBV. Genotype analysis was performed for three single nucleotide polymorphisms (SNPs) of HLA-F and one SNP of HLA-E using PCR-SSP, in 252 Tunisian patients with chronic HBV infection stratified according to their HBV DNA levels (140 patients with low HBV DNA levels < 2000 IU/mL and 112 patients with high HBV DNA levels ≥ 2000 IU/mL) and 240 healthy controls (CTRL). The three HLA-F SNPs (HLA-F*01:02, -F*01:03 and -F*01:04) have the same allelic and genotypic frequencies in patients and in CTRL. We reported a low HLA-F*01:02 and F*01:04 allelic frequencies in the Tunisian population; however, high HLA-F*01:03 allele frequencies were observed (17%). A significant association was found between the HLA-F*01:03 allele and decreased level of HBV DNA (P = 0.02 OR 0.56, 95% CI 0.35-0.92). No significant differences were observed in haplotype distribution between patients and CTRL. A significant association of HLA-F*01:03 with the level of HBV DNA suggests an important role of HLA-F in HBV replication control.Entities:
Keywords: Chronic hepatitis; Fibrosis; Hepatitis B virus; Human leukocyte antigen-F; Single nucleotide polymorphism
Year: 2018 PMID: 29354360 PMCID: PMC5752667 DOI: 10.1007/s13205-017-1079-9
Source DB: PubMed Journal: 3 Biotech ISSN: 2190-5738 Impact factor: 2.406